Suchergebnisse - "ZHAO JIAN"

PubPharm (71)

1

Comparation of the effectiveness of conventional needle irrigation and photon-induced photoacoustic streaming with sodium hypochorite in the treatment of teeth with apical periodontitis : a randomized clinical trial

enthalten in: BMC oral health | 2024

von Zhao, J. | Wu, S. | Huang, Y. | +5

2

Single-Cell Enzymatic Screening for Epithelial Mesenchymal Transition with an Ultrasensitive Superwetting Droplet-Array Microchip

enthalten in: Small methods | 2023

von Xiao, X. | Miao, X. | Duan, S. | +11

3

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC : Extended Follow-Up of CameL Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Zhou, C. | Chen, G. | Huang, Y. | +54

4

Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations : a phase 2 randomized trial

enthalten in: Nature medicine | 2023

von Rosenson, R. | Gaudet, D. | Ballantyne, C. | +14

5

Clinical Efficacy of Potato Extract for Alleviating Chemoradiotherapy-Related Leukopenia : a Randomized, Single-Blind, Placebo-Controlled Trial

enthalten in: Clinical laboratory | 2022

von Bao, Y. | Eerdemutu | An, Z. | +4

6

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Wang, J. | Zhou, C. | Yao, W. | +79

CommentIn: Lancet Oncol. 2022 Jun;23(6):692-693. - PMID 35576958

7

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2022

von Forde, P. | Spicer, J. | Lu, S. | +127

CommentIn: N Engl J Med. 2022 May 26;386(21):2050-2051. - PMID 35403840

8

XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer : An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX)

enthalten in: Cancer communications (London, England) | 2022

von Zhu, X. | Huang, M. | Wang, Y. | +31

9

Trastuzumab Plus Endocrine Therapy or Chemotherapy as First-line Treatment for Patients with Hormone Receptor-Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Hua, X. | Bi, X. | Zhao, J. | +19

10

Management of Patients with Cervicofacial Edema and Paresthesia during Perioperative Period of Transoral Endoscopic Thyroidectomy

enthalten in: Computational and mathematical methods in medicine | 2022

von Yang, X. | Zhao, J. | Liu, M. | +2

RetractionIn: Comput Math Methods Med. 2023 Aug 2;2023:9869456. - PMID 37564767

1
2
3
4
5
6
7
8
Nächster »
[8]